Evidence map›Paper›PMID 40440352›Full record

ArticlePloS one2025

Exploring the impact of mobile and migrant populations on mass drug administration coverage and effectiveness in Africa: A scoping review protocol.

Moussa Sangare, Yaya Ibrahim Coulibaly, Prithi Ravichandran, Abdoul Fatao Diabate, Claudia Duguay, Carol Vlassoff, Manisha A Kulkarni, Alison Krentel

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07707817 (A Community Mapping and Participatory Research Protocol for Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations Through Social and Occupational Networks in Nigeria), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07707817 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Community Mapping and Participatory Research Protocol for Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations Through Social and Occupational Networks in Nigeria: MISSION Nigeria

TypeinterventionalSponsorUwemedimo Friday EkpoRan2026 to 2027Enrolled5,760ConditionsOnchocerciasis (River Blindness), Schistosomiasis, Soil Transmitted Helminth (STH) Infections, Lymphatic FilariasisArmsModified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg, Ivermectin, Ivermectin + albendazole
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Moussa SangareInternational Center of Excellence in Research in Mali, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.ORCID https://orcid.org/0000-0001-9582-4093
Yaya Ibrahim CoulibalyInterdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Prithi RavichandranBruyère Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Abdoul Fatao DiabateInternational Center of Excellence in Research in Mali, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Claudia DuguayBruyère Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Carol VlassoffSchool of Epidemiology and Public Heath, University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada.
Manisha A KulkarniSchool of Epidemiology and Public Heath, University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada.
Alison KrentelBruyère Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeglected tropical diseases (NTDs) affect populations in tropical regions, particularly low- and middle-income countries with limited economic and health resources. Mass drug administration (MDA) is a strategy for controlling and eliminating NTDs by treating entire at-risk populations to reduce parasite loads, interrupt transmission, and prevent reinfection. It is cost-effective, and promotes equity by reaching underserved communities. MDA is a critical approach to controlling and eliminating NTDs. Mobile populations in Africa such as nomadic groups and internally displaced persons, may lack access to MDA, which poses challenges to NTD elimination. This study aims to explore the influence of population mobility on the implementation, effectiveness, and sustainability of MDA in Africa. MATERIALS AND

methodsThis scoping review adheres to the PRISMA extension for scoping reviews and Joanna Briggs Institute (JBI) methodology. PCC (Population, Concept, Context) serves as the foundation for the study. Relevant papers published after 2000 will be identified through a comprehensive search of Medline Ovid, Embase, Web of Science, and gray literature. Studies addressing challenges to MDA in Africa's and related to mobile populations will be included. An Excel spreadsheet modified from the JBI will be used for data extraction and analysis.

conclusionThe results of this review will shed light on how MDA coverage is affected by the phenomenon of mobile and migrant populations and what effective approaches, if any, have been used to address this problem and improve overall population access to MDA.

Indexed as

Mass Drug AdministrationNeglected DiseasesTransients and MigrantsAfricaHumansScoping Reviews as Topic

Identifiers

PMID40440352
PMCPMC12121756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.